Tortoise Investment Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
P
LCM
ACA
Tortoise Investment Management's CRDF Position: Q2 2025 in Review
Tortoise Investment Management sold out of Cardiff Oncology (CRDF) in Q2 2025, closing a stake of 10,000 shares — an estimated $31.4K sold.
Tortoise Investment Management first reported a position in CRDF in Q2 2020 and held it in 20 quarters. The position peaked at $450K in Q4 2020. 114 funds tracked by Wall St. Rank hold CRDF as of Q2 2025.
- Tortoise Investment Management reported no remaining Cardiff Oncology position as of Q2 2025 after selling out during the quarter.
- Tortoise Investment Management sold 10,000 Cardiff Oncology shares in Q2 2025, an estimated $31.4K.
- Tortoise Investment Management first reported a position in Cardiff Oncology in Q2 2020 and held it in 20 quarters.
- Tortoise Investment Management's Cardiff Oncology position peaked at $450K in Q4 2020.
- 114 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2025.
Based on Tortoise Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.